---
figid: PMC3291787__nihms-349732-f0002
figtitle: Targeting the EGFR signaling pathway in cancer therapy
organisms:
- Mus musculus
- Rattus norvegicus
- Glycine max
- Diaporthe sclerotioides
- Homo sapiens
pmcid: PMC3291787
filename: nihms-349732-f0002.jpg
figlink: /pmc/articles/PMC3291787/figure/F2/
number: F1b
caption: EGFR can specifically bind with EGF, TGF-α, AR, BTC and EPR ligands. HER2
  is an orphan receptor with no known ligand. HER3 lacks intrinsic tyrosine kinase
  domain and binds to Herregulin-1, 2 (HRG-1&2). HER4 binds to HRG1-4, NRG1-4, HB-EGF,
  BTC and EPR.
papertitle: Targeting the EGFR signaling pathway in cancer therapy.
reftext: Parthasarathy Seshacharyulu, et al. Expert Opin Ther Targets. ;16(1):15-31.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9411291
figid_alias: PMC3291787__F1b
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC3291787__F1b
ndex: 98ab8c70-def3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3291787__nihms-349732-f0002.html
  '@type': Dataset
  description: EGFR can specifically bind with EGF, TGF-α, AR, BTC and EPR ligands.
    HER2 is an orphan receptor with no known ligand. HER3 lacks intrinsic tyrosine
    kinase domain and binds to Herregulin-1, 2 (HRG-1&2). HER4 binds to HRG1-4, NRG1-4,
    HB-EGF, BTC and EPR.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfa
  - Epgn
  - Hrg
  - Nrg1
  - Btc
  - hb
  - Ereg
  - Ar
  - Egf
  - Stc1
  - Nrg2
  - Hbegf
  - TGFA
  - HRG
  - NRG1
  - SLC48A1
  - BTC
  - GSTM1
  - NRG2
  - EREG
  - AR
  - EGF
  - STC1
  - HBEGF
  - NRG3
  - NRG4
  - LOC681544
  - Slc48a1
  - Epigen
---
